Escalation To High-Dose ICS Versus Dupilumab Initiation in Uncontrolled Asthma Patients on Medium-Dose ICS: A Matched Analysis of Administrative ClaimsRohit Katial, Aakash Bipin Gandhi, Olivier Ledanois et al.|Journal of Allergy and Clinical Immunology|2026Cited by 0
Real-World Outcomes Following Asthma Treatment Escalation From Medium-Dose ICS to high-Dose ICS or BiologicsNjira Lugogo, Aakash Bipin Gandhi, Rohit Katial et al.|Journal of Allergy and Clinical Immunology|2026Cited by 0